Primer: GenFleet Therapeutics (GENFL12 HK) - Sep 2025
GenFleet Therapeutics is a clinical-stage biopharmaceutical company with a strong focus on developing novel therapies in oncology and...
32 Views
Pre-IPO GenFleet Therapeutics (PHIP Updates) - Some Points Worth the Attention
GenFleet's IPO debut is eye-catching.Besides continuous enthusiasm for Biotech IPO, the endorsement of famous cornerstone investors brings great...
745 Views
Genfleet (劲方医药) IPO: Trading Update
Genfleet raises $233m in global offering and is set to list on HKSE on Sept 18. We provides an update prior to its trading debut.
361 Views
Genfleet (劲方医药) IPO: Margin of Safety
China-based biotech company Genfleet launches IPO in Hong Kong to raise $204 million, with positive sentiment and a margin of safety in valuation.
441 Views
Genfleet Therapeutics IPO: Finely Placed at the Moment; RAS Inhibitors Hold Key to Future Growth
Genfleet Therapeutics has filed for HK IPO to raise up to HK$1.6B. The company plans to sell 77.6M shares at HK$20.39 per share. The IPO will close...
762 Views